Primary Progressive Multiple Sclerosis: Putting Together the Puzzle

Cited by papers we hold 4

• Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis · 2019
  No notice
• Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker? · 2019
  No notice
• Serum GFAP as a biomarker for disease severity in multiple sclerosis · 2018
  Corrected
• Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.